טוען...
Prospects for a MERS-CoV spike vaccine
INTRODUCTION: Six years have passed since Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), a newly emerging infectious virus, was first reported in 2012. Although MERS-CoV has had a consistently high mortality rate in humans, no vaccines have been approved to prevent MERS-CoV infectio...
שמור ב:
| הוצא לאור ב: | Expert Rev Vaccines |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355461/ https://ncbi.nlm.nih.gov/pubmed/30058403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2018.1506702 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|